Skip to main content
. Author manuscript; available in PMC: 2013 Nov 26.
Published in final edited form as: Br J Haematol. 2008 Apr 1;141(5):10.1111/j.1365-2141.2008.07070.x. doi: 10.1111/j.1365-2141.2008.07070.x

Table IV.

Models for Time to Treatment Among Early Stage Patients

Univariate Analysis HR HR 95% CI p-value
TTT from diagnosis
  Rai stage (0 vs. 1-2) 3.05 1.74, 5.37 0.0001
  CD38 2.30 1.30, 4.04 0.004
   T:MBC ratio* 3.96 2.24, 7.00 <0.0001
  NK:MBC ratio* 4.41 2.50, 7.77 <0.0001
  MBC count* 2.42 1.37, 4.26 0.002
Multivariate Analysis
TTT from diagnosis
 Rai Stage (0 vs. 1-2) 2.20 1.23, 3.97 0.008
 CD38 NS
 T:MBC ratio* 2.07 1.04, 4.09 0.04
 NK:MBC ratio* 2.53 1.27, 5.0 0.009
 MBC count* NS
*

Categorized low vs high (see text)